Atlas Trials

Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy

Clinical trial NCT04637594 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04637594
Sponsor
Alliance for Clinical Trials in Oncology
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial CarcinomaLocally Advanced Urethral Urothelial CarcinomaLocally Advanced Urothelial CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis Urothelial CarcinomaMetastatic Ureter Urothelial CarcinomaMetastatic Urethral Urothelial CarcinomaMetastatic Urothelial Carcinoma
Start date
2022-05-27
Primary completion
2024-06-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.